Rachel Klemovitch, Assistant Editor01.03.24
In 2023 new FDA approvals and new devices were popular, as well as a look into new studies.
Philips partnered with Polarean to develop an advanced solution for evaluating lung ventilation using MR imaging. The Philips 3T MR 7700 was showcased at the 2023 International Society for Magnetic Resonance on Medicine Annual Meeting & Exhibition.
Philips also issued a Class I recall of BiPAP and CPAP machines. The Philips Respironics Trilogy 100, Trilogy 200, and Garbin Plus ventilators were recalled on December 7, as well as in June of 2021.
The FDA cleared Acurable’s AcuPebble sleep apnea test in July. Another popular article was Cochlear’s Implant Study at Mayo Clinic in January.
Philips partnered with Polarean to develop an advanced solution for evaluating lung ventilation using MR imaging. The Philips 3T MR 7700 was showcased at the 2023 International Society for Magnetic Resonance on Medicine Annual Meeting & Exhibition.
Philips also issued a Class I recall of BiPAP and CPAP machines. The Philips Respironics Trilogy 100, Trilogy 200, and Garbin Plus ventilators were recalled on December 7, as well as in June of 2021.
The FDA cleared Acurable’s AcuPebble sleep apnea test in July. Another popular article was Cochlear’s Implant Study at Mayo Clinic in January.
- The 2023 MPO Top 30 Medical Device Companies Report
- Reflections on 2022 and What’s Ahead for Medtech: MPO Sounding Board
- FDA Clears Acurable's Sleep Apnea Testing Device
- 4 Questions to Help Device Manufacturers Assess Their Employee Retention Credit Eligibility
- Philips Recall of Previously Recalled, Repaired Ventilators Deemed Class I
- Philips Partners with Polarea to Advance Ventilation Imaging
- Cochlear Implant Study Underway at Mayo Clinic
- RJG Names Winners of 2023 RJG Mold Smart Award
- New and Developing Diabetes Technologies Offer 'Sweet Relief'
- Labcorp's Clinical Development Spinoff to be Called Fortrea